Raymond Wood
Direttore/Membro del Consiglio presso Cell Therapies Pty Ltd.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Robert Adair | M | - |
Cleantech Ventures Pty Ltd.
Cleantech Ventures Pty Ltd. Investment ManagersFinance Cleantech Ventures Pty Ltd (Cleantech Ventures) is a venture capital investment firm founded by Jan Dekker and Andrew Pickering. The firm is headquartered in Melbourne, Australia. | - |
Jan Dekker | M | - |
Cleantech Ventures Pty Ltd.
Cleantech Ventures Pty Ltd. Investment ManagersFinance Cleantech Ventures Pty Ltd (Cleantech Ventures) is a venture capital investment firm founded by Jan Dekker and Andrew Pickering. The firm is headquartered in Melbourne, Australia. | 17 anni |
Michael Wyzga | M | 69 |
Carina Biotech Pty Ltd.
Carina Biotech Pty Ltd. BiotechnologyHealth Technology Carina Biotech Pty Ltd. is an immuno-oncology company based in Mawson Lakes, Australia. The Australian company is developing CAR-T and other adoptive cell therapies to treat solid cancers. Carina Biotech has a deep pipeline of CAR-T programs, including its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer. The private company aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects. Carina Biotech also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients. The CEO of the company is Deborah A. Rathjen. | 1 anni |
Deborah Rathjen | M | - |
Carina Biotech Pty Ltd.
Carina Biotech Pty Ltd. BiotechnologyHealth Technology Carina Biotech Pty Ltd. is an immuno-oncology company based in Mawson Lakes, Australia. The Australian company is developing CAR-T and other adoptive cell therapies to treat solid cancers. Carina Biotech has a deep pipeline of CAR-T programs, including its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer. The private company aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects. Carina Biotech also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients. The CEO of the company is Deborah A. Rathjen. | - |
Joseph M. Younane | M | - |
Cleantech Ventures Pty Ltd.
Cleantech Ventures Pty Ltd. Investment ManagersFinance Cleantech Ventures Pty Ltd (Cleantech Ventures) is a venture capital investment firm founded by Jan Dekker and Andrew Pickering. The firm is headquartered in Melbourne, Australia. | - |
Charlie Latham | M | 69 |
Carina Biotech Pty Ltd.
Carina Biotech Pty Ltd. BiotechnologyHealth Technology Carina Biotech Pty Ltd. is an immuno-oncology company based in Mawson Lakes, Australia. The Australian company is developing CAR-T and other adoptive cell therapies to treat solid cancers. Carina Biotech has a deep pipeline of CAR-T programs, including its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer. The private company aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects. Carina Biotech also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients. The CEO of the company is Deborah A. Rathjen. | - |
Matthew Cuthbertson | M | - |
Cleantech Ventures Pty Ltd.
Cleantech Ventures Pty Ltd. Investment ManagersFinance Cleantech Ventures Pty Ltd (Cleantech Ventures) is a venture capital investment firm founded by Jan Dekker and Andrew Pickering. The firm is headquartered in Melbourne, Australia. | - |
Remus Vezan | M | - |
Carina Biotech Pty Ltd.
Carina Biotech Pty Ltd. BiotechnologyHealth Technology Carina Biotech Pty Ltd. is an immuno-oncology company based in Mawson Lakes, Australia. The Australian company is developing CAR-T and other adoptive cell therapies to treat solid cancers. Carina Biotech has a deep pipeline of CAR-T programs, including its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer. The private company aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects. Carina Biotech also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients. The CEO of the company is Deborah A. Rathjen. | 1 anni |
Stephen Livesey | M | - |
Carina Biotech Pty Ltd.
Carina Biotech Pty Ltd. BiotechnologyHealth Technology Carina Biotech Pty Ltd. is an immuno-oncology company based in Mawson Lakes, Australia. The Australian company is developing CAR-T and other adoptive cell therapies to treat solid cancers. Carina Biotech has a deep pipeline of CAR-T programs, including its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer. The private company aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects. Carina Biotech also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients. The CEO of the company is Deborah A. Rathjen. | - |
Leanna Read | M | - |
Carina Biotech Pty Ltd.
Carina Biotech Pty Ltd. BiotechnologyHealth Technology Carina Biotech Pty Ltd. is an immuno-oncology company based in Mawson Lakes, Australia. The Australian company is developing CAR-T and other adoptive cell therapies to treat solid cancers. Carina Biotech has a deep pipeline of CAR-T programs, including its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer. The private company aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects. Carina Biotech also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients. The CEO of the company is Deborah A. Rathjen. | - |
Peter Turvey | M | 73 |
Cell Therapies Pty Ltd.
| - |
Andrew Pickering | M | - |
Cleantech Ventures Pty Ltd.
Cleantech Ventures Pty Ltd. Investment ManagersFinance Cleantech Ventures Pty Ltd (Cleantech Ventures) is a venture capital investment firm founded by Jan Dekker and Andrew Pickering. The firm is headquartered in Melbourne, Australia. | 17 anni |
Julian Turecek | M | - |
Cleantech Ventures Pty Ltd.
Cleantech Ventures Pty Ltd. Investment ManagersFinance Cleantech Ventures Pty Ltd (Cleantech Ventures) is a venture capital investment firm founded by Jan Dekker and Andrew Pickering. The firm is headquartered in Melbourne, Australia. | 16 anni |
Mark Bonnar | M | - |
Cleantech Ventures Pty Ltd.
Cleantech Ventures Pty Ltd. Investment ManagersFinance Cleantech Ventures Pty Ltd (Cleantech Ventures) is a venture capital investment firm founded by Jan Dekker and Andrew Pickering. The firm is headquartered in Melbourne, Australia. | 16 anni |
Bill Nikolovski | M | - |
Cleantech Ventures Pty Ltd.
Cleantech Ventures Pty Ltd. Investment ManagersFinance Cleantech Ventures Pty Ltd (Cleantech Ventures) is a venture capital investment firm founded by Jan Dekker and Andrew Pickering. The firm is headquartered in Melbourne, Australia. | - |
Suzanne Ridding | F | - |
Carina Biotech Pty Ltd.
Carina Biotech Pty Ltd. BiotechnologyHealth Technology Carina Biotech Pty Ltd. is an immuno-oncology company based in Mawson Lakes, Australia. The Australian company is developing CAR-T and other adoptive cell therapies to treat solid cancers. Carina Biotech has a deep pipeline of CAR-T programs, including its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer. The private company aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects. Carina Biotech also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients. The CEO of the company is Deborah A. Rathjen. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Australia | 16 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Raymond Wood
- Contatti personali